PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2022.3432023552636-642Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the BladderHongsik Kim, Byong Chang Jeong, Joohyun Hong, Ghee Young Kwon, Chan Kyo Kim, Won Park, Hongryull Pyo, Wan Song, Hyun Hwan Sung, Jung Yong Hong, Se Hoon Parkhttp://e-crt.org/upload/pdf/crt-2022-343.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2022.343, http://e-crt.org/upload/pdf/crt-2022-343.pdf
Urologic Oncology: Seminars and Original Investigations10.1016/j.urolonc.2009.03.0032009273338Commentary on A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: A retrospective experienceH. Barton Grossmanhttps://api.elsevier.com/content/article/PII:S1078143909000775?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1078143909000775?httpAccept=text/plain
Investigative and Clinical Urology10.4111/icu.202104072022632168Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladderHyun Hwan Sung, Hana Kim, Ryul Kim, Chan Kyo Kim, Ghee Young Kwon, Won Park, Wan Song, Byong Chang Jeong, Se Hoon Parkhttps://icurology.org/pdf/10.4111/icu.20210407, https://icurology.org/DOIx.php?id=10.4111/icu.20210407, https://icurology.org/DOIx.php?id=10.4111/icu.20210407
Cancer10.1002/cncr.23848200811392471-2477A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladderAtreya Dash, Joseph A. Pettus, Harry W. Herr, Bernard H. Bochner, Guido Dalbagni, S. Machele Donat, Paul Russo, Mary G. Boyle, Matthew I. Milowsky, Dean F. Bajorinhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.23848, http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.23848/fullpdf
Robotic Urology10.1007/978-3-319-65864-3_212018241-248Neoadjuvant Chemotherapy in Muscle Invasive Urothelial Bladder CancerGünter Niegisch, Peter Albershttp://link.springer.com/content/pdf/10.1007/978-3-319-65864-3_21
Urologic Oncology: Seminars and Original Investigations10.1016/j.urolonc.2012.07.00520133181737-1743Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: A retrospective analysis from the University of Southern CaliforniaAdrian S. Fairey, Siamak Daneshmand, David Quinn, Tanya Dorff, Ryan Dorin, Gary Lieskovsky, Anne Schuckman, Jie Cai, Gus Miranda, Eila C. Skinnerhttps://api.elsevier.com/content/article/PII:S1078143912002475?httpAccept=text/plain, https://api.elsevier.com/content/article/PII:S1078143912002475?httpAccept=text/xml
Asia-Pacific Journal of Clinical Oncology10.1111/ajco.12017201294310-317Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle‐invasive bladder cancerNobuaki Matsubara, Hirofumi Mukai, Yoichi Naito, Masahiko Nezu, Kuniaki Itohhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fajco.12017, https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajco.12017, https://onlinelibrary.wiley.com/doi/full-xml/10.1111/ajco.12017, http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajco.12017/fullpdf
European Urology10.1016/j.eururo.2008.01.045200854121-23Muscle-Invasive Urothelial Carcinoma of the Bladder: Neoadjuvant Chemotherapy Enables Organ-Preserving Therapy in Carefully Selected PatientsAxel Heidenreichhttps://api.elsevier.com/content/article/PII:S0302283808000547?httpAccept=text/plain, https://api.elsevier.com/content/article/PII:S0302283808000547?httpAccept=text/xml
Reports of Practical Oncology & Radiotherapy10.1016/s1507-1367(10)60016-82008136300-308Conservative treatment in patients with muscle-invasive bladder cancer by transurethral resection, neoadjuvant chemotherapy with gemcitabine and cisplatin, and accelerated radiotherapy with concomitant boost plus concurrent cisplatin – assessment of response and toxicity.Jadwiga NOWAK-SADZIKOWSKA, Teresa KOWALSKA, Jerzy JAKUBOWICZ, Teresa SZPYTMAhttps://api.elsevier.com/content/article/PII:S1507136710600168?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1507136710600168?httpAccept=text/plain
European Urology10.1016/j.eururo.2022.04.0102022822242-243Re: Phase II Study of Gemcitabine and Split-dose Cisplatin plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients with Muscle-invasive Bladder CancerEkaterina Laukhtina, Shahrokh F. Shariathttps://api.elsevier.com/content/article/PII:S0302283822018164?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0302283822018164?httpAccept=text/plain